TRAVOPROST
Marketedupdated 2mo agoby Sandoz Inc
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 2 investigational indications.
all catalysts(11)
approval · 11
Sep 21, 2006
approval
TRAVATAN Z (TRAVOPROST) — FDA approval
TRAVOPROST
→
Aug 31, 2010
approval
TRAVATAN Z (TRAVOPROST) — FDA approval
TRAVOPROST
→
Sep 7, 2011
approval
TRAVATAN Z (TRAVOPROST) — FDA approval
TRAVOPROST
→
Mar 11, 2016
approval
TRAVATAN Z (TRAVOPROST) — FDA approval
TRAVOPROST
→
Sep 22, 2017
approval
TRAVATAN Z (TRAVOPROST) — FDA approval
TRAVOPROST
→
Apr 2, 2020
approval
TRAVATAN Z (TRAVOPROST) — FDA approval
TRAVOPROST
→
Dec 13, 2023
approval
IDOSE TR (TRAVOPROST) — FDA approval
TRAVOPROST
→
Oct 9, 2025
approval
TRAVATAN Z (TRAVOPROST) — FDA approval
TRAVOPROST
→
Dec 17, 2025
approval
TRAVOPROST — FDA approval
TRAVOPROST
→
Jan 27, 2026
approval
IDOSE TR (TRAVOPROST) — FDA approval
TRAVOPROST
→
Jan 27, 2026
approval
IDOSE TR (TRAVOPROST) — FDA approval
TRAVOPROST
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that